• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[新辅助化疗后骨肉瘤肿瘤体积的预后意义]

[The prognostic significance of tumor volume in osteosarcoma with neoadjuvant chemotherapy].

作者信息

Rehan N, Bieling P, Winkler P, Helmke K, Maas R, Baldini N, Heise U, Fuchs N, Winkler K

机构信息

Abt. für Pädiatrische Hämatologie und Onkologie, Universität Hamburg.

出版信息

Klin Padiatr. 1993 Jul-Aug;205(4):200-9. doi: 10.1055/s-2007-1025228.

DOI:10.1055/s-2007-1025228
PMID:8377444
Abstract

In a retrospective analysis on 128 patients from the trials COSS-80, -82, -85 and -86 initial x-ray pictures were evaluated for tumor diameters in three planes and the prognostic meaning on survival was assessed. In a subset of patients (n = 27) the measured values were compared to values obtained by CT-Scan and a good correlation (r = 0.69) was found. Several parameters for tumor size were defined: absolute tumor length (ATL), relative tumor length (RTL, proportion of tumor to the length of the involved bone), absolute tumor volume (ATV, calculated by the ellipsoid formula) and relative tumor volume (RTL, tumor volume referred to the body surface area) and univariate and multivariate survival analysis were performed. Univariate analysis of metastasis free survival (MFS) revealed a high prognostic significance of the ATL, the ATV and the RTV. The RTL in this patient group demonstrated a tendency only toward an inferior prognosis in larger tumors. None of the patients with a ATV < 70 ml (n = 19) and only one of 33 patients with an ATV < 100 ml relapsed. Cox regression analysis was performed including the variables age, sex, site and response (> 90% tumor necrosis) in 84 patients. ATL and RTL do not enter the model, while the response proves its significance as a valid prognostic factor with a p-value of 0.0004. Adding the ATV as the measure of tumor size to the model it enters as the first term (p = 0.0000) followed by the response (p = 0.0002).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在对来自COSS - 80、- 82、- 85和- 86试验的128例患者进行的回顾性分析中,评估了初始X线片上肿瘤在三个平面的直径,并评估了其对生存的预后意义。在一部分患者(n = 27)中,将测量值与CT扫描获得的值进行比较,发现相关性良好(r = 0.69)。定义了几个肿瘤大小参数:绝对肿瘤长度(ATL)、相对肿瘤长度(RTL,肿瘤长度与受累骨长度的比例)、绝对肿瘤体积(ATV,通过椭球体公式计算)和相对肿瘤体积(RTV,肿瘤体积相对于体表面积),并进行了单变量和多变量生存分析。无转移生存(MFS)的单变量分析显示,ATL、ATV和RTV具有较高的预后意义。该患者组中的RTL仅在较大肿瘤中显示出预后较差的趋势。ATV < 70 ml的患者无一例复发(n = 19),ATV < 100 ml的33例患者中只有1例复发。对84例患者进行了Cox回归分析,纳入了年龄、性别、部位和反应(> 90%肿瘤坏死)等变量。ATL和RTL未进入模型,而反应作为一个有效的预后因素具有显著意义,p值为0.0004。将ATV作为肿瘤大小的指标加入模型后,它作为第一项进入模型(p = 0.0000),其次是反应(p = 0.0002)。(摘要截断于250字)

相似文献

1
[The prognostic significance of tumor volume in osteosarcoma with neoadjuvant chemotherapy].[新辅助化疗后骨肉瘤肿瘤体积的预后意义]
Klin Padiatr. 1993 Jul-Aug;205(4):200-9. doi: 10.1055/s-2007-1025228.
2
Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.原发性转移性骨肉瘤:接受新辅助骨肉瘤协作研究组方案治疗患者的表现及预后
J Clin Oncol. 2003 May 15;21(10):2011-8. doi: 10.1200/JCO.2003.08.132.
3
Tumor size and prognosis in aggressively treated osteosarcoma.积极治疗的骨肉瘤的肿瘤大小与预后
J Clin Oncol. 1996 Mar;14(3):848-58. doi: 10.1200/JCO.1996.14.3.848.
4
Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients.通过肿瘤体积变化调整后的肿瘤坏死率是局限性骨肉瘤患者生存的更好预测指标。
Ann Surg Oncol. 2008 Mar;15(3):906-14. doi: 10.1245/s10434-007-9779-8. Epub 2007 Dec 28.
5
Post operative infection and increased survival in osteosarcoma patients: are they associated?骨肉瘤患者术后感染与生存率提高:二者有关联吗?
Ann Surg Oncol. 2007 Oct;14(10):2887-95. doi: 10.1245/s10434-007-9483-8. Epub 2007 Jul 26.
6
Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.新辅助化疗治疗肢体骨肉瘤的预后因素:单机构789例患者的15年经验
Cancer. 2006 Mar 1;106(5):1154-61. doi: 10.1002/cncr.21724.
7
[Prognostic factors for 72 patients with osteosarcoma of the extremity treated with neoadjuvant chemotherapy].[72例接受新辅助化疗的肢体骨肉瘤患者的预后因素]
Zhonghua Wai Ke Za Zhi. 2008 Aug 1;46(15):1166-70.
8
Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).综合治疗后骨肉瘤复发:对骨肉瘤协作研究组(COSS)中未经挑选患者的分析。
J Clin Oncol. 2005 Jan 20;23(3):559-68. doi: 10.1200/JCO.2005.04.063.
9
[Therapy-induced changes in osteosarcoma after neoadjuvant chemotherapy (COSS 86 Therapy Study). Correlation between morphologic findings and clinical follow-up].[新辅助化疗后骨肉瘤的治疗诱导变化(COSS 86治疗研究)。形态学结果与临床随访之间的相关性]
Pathologe. 1996 Jan;17(1):35-43.
10
Prognostic relevance of increased angiogenesis in osteosarcoma.骨肉瘤中血管生成增加的预后相关性
Clin Cancer Res. 2004 Dec 15;10(24):8531-7. doi: 10.1158/1078-0432.CCR-04-0969.

引用本文的文献

1
Establishment, Maintenance, and Performance of the Cooperative Osteosarcoma Study Group (COSS).骨肉瘤协作研究组(COSS)的组建、维持及成效
Cancers (Basel). 2023 Feb 28;15(5):1520. doi: 10.3390/cancers15051520.
2
Meta-analysis of limb salvage versus amputation for treating high-grade and localized osteosarcoma in patients with pathological fracture.肢体挽救与截肢治疗病理性骨折的高级别局限性骨肉瘤患者的荟萃分析。
Exp Ther Med. 2012 Nov;4(5):889-894. doi: 10.3892/etm.2012.685. Epub 2012 Aug 28.